5-180848815-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001172638.2(ZFP62):c.2680G>A(p.Gly894Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000241 in 1,538,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001172638.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZFP62 | NM_001172638.2 | c.2680G>A | p.Gly894Ser | missense_variant | 2/2 | ENST00000502412.2 | NP_001166109.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZFP62 | ENST00000502412.2 | c.2680G>A | p.Gly894Ser | missense_variant | 2/2 | 2 | NM_001172638.2 | ENSP00000423820.1 | ||
ZFP62 | ENST00000506377.5 | n.254-733G>A | intron_variant | 1 | ||||||
ZFP62 | ENST00000512132.5 | c.2581G>A | p.Gly861Ser | missense_variant | 3/3 | 2 | ENSP00000426193.1 | |||
ZFP62 | ENST00000507843.1 | n.363+339G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000721 AC: 11AN: 152658Hom.: 0 AF XY: 0.0000372 AC XY: 3AN XY: 80738
GnomAD4 exome AF: 0.0000202 AC: 28AN: 1385708Hom.: 0 Cov.: 34 AF XY: 0.0000132 AC XY: 9AN XY: 681046
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74468
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at